203 related articles for article (PubMed ID: 30431663)
1. Traditional Chinese medicine as targeted treatment for epithelial-mesenchymal transition-induced cancer progression.
Liu J; Ke F; Cheng H; Zhou J
J Cell Biochem; 2019 Feb; 120(2):1068-1079. PubMed ID: 30431663
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effect of melatonin on hypoxia-induced vasculogenic mimicry via suppressing epithelial-mesenchymal transition (EMT) in breast cancer stem cells.
Maroufi NF; Amiri M; Dizaji BF; Vahedian V; Akbarzadeh M; Roshanravan N; Haiaty S; Nouri M; Rashidi MR
Eur J Pharmacol; 2020 Aug; 881():173282. PubMed ID: 32580038
[TBL] [Abstract][Full Text] [Related]
3. The relationship between vasculogenic mimicry and epithelial-mesenchymal transitions.
Liu Q; Qiao L; Liang N; Xie J; Zhang J; Deng G; Luo H; Zhang J
J Cell Mol Med; 2016 Sep; 20(9):1761-9. PubMed ID: 27027258
[TBL] [Abstract][Full Text] [Related]
4. A new perspective of vasculogenic mimicry: EMT and cancer stem cells (Review).
Fan YL; Zheng M; Tang YL; Liang XH
Oncol Lett; 2013 Nov; 6(5):1174-1180. PubMed ID: 24179490
[TBL] [Abstract][Full Text] [Related]
5. Traditional Chinese medicine for prevention and treatment of hepatocellular carcinoma: A focus on epithelial-mesenchymal transition.
Li JJ; Liang Q; Sun GC
J Integr Med; 2021 Nov; 19(6):469-477. PubMed ID: 34538644
[TBL] [Abstract][Full Text] [Related]
6. Current Advance of Therapeutic Agents in Clinical Trials Potentially Targeting Tumor Plasticity.
Yang XG; Zhu LC; Wang YJ; Li YY; Wang D
Front Oncol; 2019; 9():887. PubMed ID: 31552191
[TBL] [Abstract][Full Text] [Related]
7. Traditional Chinese Medicines as Effective Reversals of Epithelial-Mesenchymal Transition Induced-Metastasis of Colorectal Cancer: Molecular Targets and Mechanisms.
Ge H; Xu C; Chen H; Liu L; Zhang L; Wu C; Lu Y; Yao Q
Front Pharmacol; 2022; 13():842295. PubMed ID: 35308223
[TBL] [Abstract][Full Text] [Related]
8. Epithelial-to-endothelial transition and cancer stem cells: two cornerstones of vasculogenic mimicry in malignant tumors.
Sun B; Zhang D; Zhao N; Zhao X
Oncotarget; 2017 May; 8(18):30502-30510. PubMed ID: 27034014
[TBL] [Abstract][Full Text] [Related]
9. Epithelial cell adhesion molecule and epithelial-mesenchymal transition are associated with vasculogenic mimicry, poor prognosis, and metastasis of triple negative breast cancer.
Wu Q; Wang J; Liu Y; Gong X
Int J Clin Exp Pathol; 2019; 12(5):1678-1689. PubMed ID: 31933986
[TBL] [Abstract][Full Text] [Related]
10. Pan-cancer dissection of vasculogenic mimicry characteristic to provide potential therapeutic targets.
Tang H; Chen L; Liu X; Zeng S; Tan H; Chen G
Front Pharmacol; 2024; 15():1346719. PubMed ID: 38694917
[TBL] [Abstract][Full Text] [Related]
11. Emerging targets in pancreatic cancer: epithelial-mesenchymal transition and cancer stem cells.
Castellanos JA; Merchant NB; Nagathihalli NS
Onco Targets Ther; 2013 Sep; 6():1261-7. PubMed ID: 24049451
[TBL] [Abstract][Full Text] [Related]
12. Regulatory mechanisms and therapeutic targeting of vasculogenic mimicry in hepatocellular carcinoma.
Zheng N; Zhang S; Wu W; Zhang N; Wang J
Pharmacol Res; 2021 Apr; 166():105507. PubMed ID: 33610718
[TBL] [Abstract][Full Text] [Related]
13. Tumor microenvironment and epithelial mesenchymal transition as targets to overcome tumor multidrug resistance.
Erin N; Grahovac J; Brozovic A; Efferth T
Drug Resist Updat; 2020 Dec; 53():100715. PubMed ID: 32679188
[TBL] [Abstract][Full Text] [Related]
14. Anticancer effects of Traditional Chinese Medicine on epithelial-mesenchymal transition（EMT） in breast cancer: Cellular and molecular targets.
Lu Y; Ding Y; Wei J; He S; Liu X; Pan H; Yuan B; Liu Q; Zhang J
Eur J Pharmacol; 2021 Sep; 907():174275. PubMed ID: 34214582
[TBL] [Abstract][Full Text] [Related]
15. Microbial metabolite deoxycholic acid promotes vasculogenic mimicry formation in intestinal carcinogenesis.
Song X; An Y; Chen D; Zhang W; Wu X; Li C; Wang S; Dong W; Wang B; Liu T; Zhong W; Sun T; Cao H
Cancer Sci; 2022 Feb; 113(2):459-477. PubMed ID: 34811848
[TBL] [Abstract][Full Text] [Related]
16. A mechanism-based computational model to capture the interconnections among epithelial-mesenchymal transition, cancer stem cells and Notch-Jagged signaling.
Bocci F; Jolly MK; George JT; Levine H; Onuchic JN
Oncotarget; 2018 Jul; 9(52):29906-29920. PubMed ID: 30042822
[TBL] [Abstract][Full Text] [Related]
17. ZEB2 promotes vasculogenic mimicry by TGF-β1 induced epithelial-to-mesenchymal transition in hepatocellular carcinoma.
Yang Z; Sun B; Li Y; Zhao X; Zhao X; Gu Q; An J; Dong X; Liu F; Wang Y
Exp Mol Pathol; 2015 Jun; 98(3):352-9. PubMed ID: 25818166
[TBL] [Abstract][Full Text] [Related]
18. The Emerging Roles of Exosomes as EMT Regulators in Cancer.
Kim H; Lee S; Shin E; Seong KM; Jin YW; Youn H; Youn B
Cells; 2020 Apr; 9(4):. PubMed ID: 32252322
[TBL] [Abstract][Full Text] [Related]
19. Epithelial-Mesenchymal Transition in Pancreatic Cancer: A Review.
Wang S; Huang S; Sun YL
Biomed Res Int; 2017; 2017():2646148. PubMed ID: 29379795
[TBL] [Abstract][Full Text] [Related]
20. Communication Between Epithelial-Mesenchymal Plasticity and Cancer Stem Cells: New Insights Into Cancer Progression.
Zheng X; Dai F; Feng L; Zou H; Feng L; Xu M
Front Oncol; 2021; 11():617597. PubMed ID: 33968721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
